Preotact Avrupa Birliği - İngilizce - EMA (European Medicines Agency)

preotact

nps pharma holdings limited - parathyroid hormone (rdna) - osteoporosis, postmenopausal - calcium homeostasis - treatment of osteoporosis in postmenopausal women at high risk of fractures (see section 5.1).a significant reduction in the incidence of vertebral, but not hip fractures has been demonstrated.